REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.
Also called NCT02580955
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 120 participants
- Registry
-
NCT02580955
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Belgium
- Registry status
- Unknown status
Technical summary
Registry record NCT02580955. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2019-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions
- Condition
- Peripheral Arterial Disease
- Intervention (Device)
- LEGFLOW DCB
- Lead sponsor
- Flanders Medical Research Program
Record details
- Record id
cardio:ct-nct02580955- Content hash
c57bf4a75ff22c3765d66e0cd966447badd1ef34e5aeb4bbf36b8aeda416d096